Document Detail


Thrombolytic therapy in acute myocardial infarction.
MedLine Citation:
PMID:  10874525     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Early reperfusion of thrombotically occluded coronary arteries by thrombolytic therapy has become a routine option in initial therapy of acute myocardial infarction. Many efforts have been made to improve the biological properties of thrombolytic agents in terms of fibrin specificity, plasma half-life and resistance to natural plasma inhibitors, to improve adjuvant therapy and to shorten the 'pain to reperfusion' time. Numerous randomised, multicentre trials have analysed the benefit of the various thrombolytic agents and regimens, which has enabled the creation of a 'current standard of therapy'. This review presents an update on available thrombolytic agents, their biochemical and pharmacological properties and results from clinical trials.
Authors:
U Priglinger; K Huber
Related Documents :
9003815 - Intracranial hemorrhage complicating acute myocardial infarction in the era of thrombol...
7640915 - When time is precious--time lags as indicators of quality of care in acute myocardial i...
2653635 - Interventional therapy in acute myocardial infarction.
7954025 - Graded exercise testing following thrombolytic therapy for acute myocardial infarction:...
24250815 - Characterization of respiratory and cardiac motion from electro-anatomical mapping data...
921445 - Postmyocardial infarction complications requiring surgery.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drugs & aging     Volume:  16     ISSN:  1170-229X     ISO Abbreviation:  Drugs Aging     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2000-09-13     Completed Date:  2000-10-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9102074     Medline TA:  Drugs Aging     Country:  NEW ZEALAND    
Other Details:
Languages:  eng     Pagination:  301-12     Citation Subset:  IM    
Affiliation:
Department of Cardiology, University of Vienna Medical School, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Pharmaceutic / therapeutic use*
Age Factors
Aged
Drug Therapy, Combination
Fibrinolytic Agents / contraindications,  pharmacology,  therapeutic use*
Humans
Middle Aged
Multicenter Studies as Topic
Myocardial Infarction / drug therapy*
Randomized Controlled Trials as Topic
Risk Factors
Chemical
Reg. No./Substance:
0/Adjuvants, Pharmaceutic; 0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfun...
Next Document:  Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients.